Nucleo cmp - Español -

Nucleo cmp "forte" 30 capsulas

Neuralgias (lumbago, ciática, otalgias, etc), neuritis (herpes zoster, parálisis facial, polineuritis, recuperación de hemipléjicos, poliomielíticos, etc).

See related drugs

Nucleo cmp Description, Presentation and Dosage

Nucleo cmp Description

Nucleo cmp Drug Class Description

Complejo b, otras asociaciones

Nucleo cmp Drug Description

CAPSULAS

Nucleo cmp Presentation

Nucleo cmp Presentation

Vía im ("Forte"):. - Adultos: 1 inyectable cada 24 h. - Niños: medio inyectable cada 24 h o 1 inyectable cada 48-72 h. Vía oral ("Normal" y "forte"):. - Adultos: 1 cápsula 3 veces al día. - Niños: 1 cápsula 2 veces al día.

Nucleo cmp Manufacturer

FERRER INTERNACIONAL

Updated

01 January 2000

Nucleo cmp Dosage

Nucleo cmp Precautions, Reactions and Contraindications

Nucleo cmp Special Precautions

Related News

Norgine launches Setofilm in the United Kingdom for the prevention of Nausea

Read more

Phase III study of Tyverb/Tykerb (Glaxo Smith Kline) fails to meet endpoint for Gastric Cancer

Read more

FDA approves Endurant II AUI graft stent (Medtronic) for Abdominal Aortic or Aorto-iliac Aneurysms

Read more

Phase III study of NEPA (Helsinn and Eisai) meets endpoint in patients with Nausea

Read more

ASPECCT study of Vectibix (Amgen) compared to Erbitux in treatment of Colorectal Cancer

Read more

FDA approves Amitiza(Sucampo/Takeda) for Opioid-induced Constipation

Read more

FDA approves Diclegis (Duchesnay USA) for treatment of Nausea in pregnancy

Read more

FDA issues Complete Response Letter to AP Pharma relating to AP F 530 for CINV

Read more

Takeda files vedolizumab at EMA for Crohns and Ulcerative Colitis

Read more

Phase III trial of Naloxegol (AstraZeneca) confirms earlier safety studies in patients with Opioid-induced Constipation

Read more

Recent Updates

Drugs

Read more

ACTILEVOL OREX 20 SOBRES

Read more

ACIDION 60 COMPRIMIDOS

Read more

ORALSONE 2.5 MG ADULTOS 12 COMP

Read more

ANAGASTRA 40 MG 28 COMPR FRASCO

Read more

LAXVITAL 30 SOBRES

View all

Clinical Guidelines

Read more

Dyspepsia: Managing dyspepsia in adults in primary care

Read more

Eating disorders, Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders

Read more

Irritable bowel syndrome in adults: Diagnosis and management of irritable bowel syndrome in primary care

Read more

Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children

View all

Medical Journals

Read more

Functional Connectivity of the Default Mode Network and Its Association With Pain Networks in Irritable Bowel Patients Assessed via Lidocaine Treatment

Read more

Interpretation and Management of Hepatic Abnormalities in Pregnancy

Read more

Long-Term Follow Up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients with Inflammatory Bowel Disease

Read more

Dietary Cholesterol Intake is Associated with Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the HALT-C trial

epgonline.org Social

Back to top